• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟原虫性贫血中红细胞生成素水平升高。

Increased erythroferrone levels in malarial anaemia.

机构信息

Institute of Laboratory Medicine, Cantonal Hospital Aarau, Aarau, Switzerland.

Graduate School for Cellular & Biomedical Sciences, University of Bern, Bern, Switzerland.

出版信息

Br J Haematol. 2024 May;204(5):2066-2070. doi: 10.1111/bjh.19309. Epub 2024 Jan 26.

DOI:10.1111/bjh.19309
PMID:38279554
Abstract

We assessed the diagnostic potential of erythroferrone as a biomarker for iron homeostasis comparing iron deficiency cases with anaemia of inflammation and controls. The dysregulation of the hepcidin axis was observed by Latour et al. in a mouse model of malarial anaemia induced by prolonged Plasmodium infection leading to increased erythroferrone concentrations. In line with that, we found significantly higher erythroferrone levels in cases with malaria and anaemia in an African population, compared to asymptomatic controls. Therefore, our findings extend the previous ones of the mouse model, suggesting also a dysregulation of the hepcidin axis in humans, which should be further corroborated in prospective studies and may lay the basis for the development of improved treatment strategies according to ERFE concentrations in such patients.

摘要

我们评估了红细胞生成素作为铁稳态生物标志物的诊断潜力,将缺铁病例与炎症性贫血和对照组进行了比较。Latour 等人在由长期疟原虫感染引起的疟原虫性贫血小鼠模型中观察到铁调素轴的失调,导致红细胞生成素浓度增加。与此一致,我们发现在非洲人群中,疟疾和贫血病例的红细胞生成素水平明显高于无症状对照组。因此,我们的研究结果扩展了之前在小鼠模型中的发现,表明人类铁调素轴也存在失调,这需要在前瞻性研究中进一步证实,并可能为根据此类患者的 ERFE 浓度制定改进的治疗策略奠定基础。

相似文献

1
Increased erythroferrone levels in malarial anaemia.疟原虫性贫血中红细胞生成素水平升高。
Br J Haematol. 2024 May;204(5):2066-2070. doi: 10.1111/bjh.19309. Epub 2024 Jan 26.
2
Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia.在疟疾贫血小鼠模型中,促红细胞生成素铁调节蛋白有助于抑制铁调素。
Haematologica. 2017 Jan;102(1):60-68. doi: 10.3324/haematol.2016.150227. Epub 2016 Sep 22.
3
Erythroferrone and iron status parameters levels in pediatric patients with iron deficiency anemia.小儿缺铁性贫血患者的红细胞生成素和铁状态参数水平。
Eur J Haematol. 2018 Apr;100(4):356-360. doi: 10.1111/ejh.13021. Epub 2018 Feb 7.
4
Hepcidin-25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.亚铁柠檬酸水合物治疗的血液透析患者中,hepcidin-25/erythroferrone 比值可预测贫血的改善。
Nephrology (Carlton). 2019 Aug;24(8):819-826. doi: 10.1111/nep.13495. Epub 2019 Apr 29.
5
Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.通过红细胞生成素-铁调素轴对镰状细胞病中铁稳态的调节。
Br J Haematol. 2020 Jun;189(6):1204-1209. doi: 10.1111/bjh.16498. Epub 2020 Feb 6.
6
Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.海拔和重组人红细胞生成素对铁代谢的影响:一项随机对照试验。
Am J Physiol Regul Integr Comp Physiol. 2021 Aug 1;321(2):R152-R161. doi: 10.1152/ajpregu.00070.2021. Epub 2021 Jun 23.
7
Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.同种异体造血干细胞移植过程中促红细胞生成素和铁调素作为红细胞生成和铁代谢之间的中介。
Am J Hematol. 2021 Oct 1;96(10):1275-1286. doi: 10.1002/ajh.26300. Epub 2021 Aug 24.
8
Iron delocalisation in the pathogenesis of malarial anaemia.铁离子定位与疟原虫贫血发病机制。
Trans R Soc Trop Med Hyg. 2010 Mar;104(3):175-84. doi: 10.1016/j.trstmh.2009.08.007. Epub 2009 Sep 23.
9
Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion.抗 TNF 治疗通过调节原血红素肽改善炎症性肠病的铁供应,其作用方式与 IL-6 有关。
Can J Gastroenterol Hepatol. 2017;2017:6843976. doi: 10.1155/2017/6843976. Epub 2017 Jan 16.
10
Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.红细胞生成素与红细胞生成及铁代谢生物标志物之间的关联,以及血液透析患者长期使用促红细胞生成剂的治疗情况。
PLoS One. 2016 Mar 15;11(3):e0151601. doi: 10.1371/journal.pone.0151601. eCollection 2016.

引用本文的文献

1
Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Erythroferrone in Anemic Rats with Chronic Kidney Disease and Chemotherapy-Induced Anemia: An Early Biomarker for Hemoglobin Response and rHuEPO Hyporesponsiveness.基于机制的红细胞生成素在慢性肾病和化疗诱导贫血的贫血大鼠中的药代动力学/药效学建模:血红蛋白反应和重组人促红细胞生成素低反应性的早期生物标志物
ACS Pharmacol Transl Sci. 2024 Dec 11;8(1):189-202. doi: 10.1021/acsptsci.4c00575. eCollection 2025 Jan 10.
2
Hormones in malaria infection: influence on disease severity, host physiology, and therapeutic opportunities.疟疾感染中的激素:对疾病严重程度、宿主生理和治疗机会的影响。
Biosci Rep. 2024 Nov 27;44(11). doi: 10.1042/BSR20240482.